- 22/12/2006 - Agreement with the ANU and Enhancement of the Antiviral Drug Development Program
- 15/12/2006 - BIT225 Presentation at International HIV Meeting, Cancun, Mexico
- 31/10/2006 - Anti-HCV Compound Presentation to International Meeting, Boston USA
- 20/10/2006 - Results of Annual General Meeting
- 20/10/2006 - Presentation to Annual General Meeting
- 19/10/2006 - Appendix 4C - Quarterly Report 30 September 2006
- 21/09/2006 - Annual Report for year ended 30 June 2006
- 20/09/2006 - Biotron Compounds Show HCV Activity
- 13/09/2006 - Appendix 4E - Preliminary Final Report 30 June 2006
- 18/07/2006 - Appendix 4C - Quarterly Report 30 June 2006
- 11/07/2006 - Manufacture of Biotron's Anti-HIV Drug BIT225
- 27/06/2006 - Presentation of Company Activities
- 24/05/2006 - Directors' Interests
- 24/04/2006 - Appendix 4C - Quarterly Report 31 March 2006
- 23/03/2006 - Revised Entitlement Issue Timetable
- 22/03/2006 - Prospectus
- 15/03/2006 - New Issues Announcement
- 15/03/2006 - Interim Financial Report 31 December 2005
- 7/03/2006 - Half Year Financial Report 31 December 2005
- 24/02/2006 - Biotron Compounds Active Against Bird Flu
- 30/01/2006 - Appendix 4C - Quarterly Report 31 December 2005
 |
 |
 |
 |
Latest share price
ASX:BIT
ASX:BIT